News

Dr Whaley Bishnoi and her team specialise in tunable nanoparticle sensors that look at local pH on an intercellular level. They use the Zetasizer Nano to measure the

The company claims that as a result of this approval, US healthcare professionals can conduct on-site chemistry analysis in less than 12 minutes for many types of conditions,

The company said that the trial 03-113 was a six-week, randomised, placebo-controlled trial in 490 patients, who had a fluorescein staining score of three in the central region

Reportedly, as part of a 2007 suit, Johnson & Johnson has alleged that Boston Scientific’s Promus Everolimus-Eluting Coronary Stent System infringed these four patents, known as the Wright/Falotico

The study conducted in 166 patients with the relapsing-remitting (RRMS) form of the disease, comprises an initial 24 week double-blind, placebo-controlled dosing period followed by a 24 week

In addition, the parties have executed a contract manufacturing services agreement under which BioLife will manufacture OriGen’s DMSO and DMSO/Dextran cryopreservation media products under sterile GMP conditions into

The company claims that the 12-gene advanced diagnostic test is clinically validated to predict individual recurrence risk in stage II colon cancer patients following surgery, as reported at

Fortis-M is a global, multicenter, randomised, double-blind, placebo-controlled phase 3 trial. It evaluates oral Talactoferrin plus best supportive care compared to placebo, plus best supportive care in patients

The authors report in the publication that the primary endpoint and key secondary endpoints of the Clarity trial were met. The Clarity data were presented at the 61st